5/A

OWNERSHIP DOCUMENT

Company: RELMADA THERAPEUTICS, INC.
Filed: February 6, 2023
Period of Report: December 31, 2022
Accession Number: 0001213900-23-008514

View Document ↗ View on SEC.gov ↗